| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Research Division, Bristol Laboratories, Syracuse, New York)
The relative in vitro susceptibility of HeLa cells and three protozoan species to a number of fermentation-derived materials was determined. Of the 61 purified agents tested in tube dilution and plate diffusion tests, 35 had displayed antitumor activity in rodents. The test system found to be most sensitive to the antitumor agents was that employing HeLa cells. Among the protozoan species, the descending order of sensitivity to tumor-active agents was as follows: Tetrahymena pyriformis, Ochromonas malhamensis, and Crithidia fasciculata. This order was not maintained in tests with the 26 tumor-inactive agents, since O. malhamensis showed the greatest susceptibility and C. fasciculata the least, while HeLa cells and T. pyriformis were intermediate. In tests with tumor-active and tumor-inactive fermentation beers, the HeLa test system very effectively distinguished between them, whereas all the protozoan species proved to be relatively poor detectors of beer antitumor agents.
* This investigation was supported in part by Cancer Chemotherapy National Service Center Contract No. Sa-43-ph-4362, National Cancer Institute, National Institutes of Health.
Received 4/23/62.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |